A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis .
Belief BioMed (Beijing) Co., Ltd
81 participants
Oct 9, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to evaluate the safety, tolerability, and efficacy of BBM-A101 to treat participants with knee osteoarthritis.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Single-dose intra-articular (IA)injection (2ml)(phase Ia) Low dose group, Middle dose group; High dose group; Control group :Placebo
Placebo(phase Ia)
Single-dose intra-articular (IA)injection (2ml)(phase Ib) Low dose group, High dose group Control group :Placebo
Placebo(phase Ib)
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07198555